The global dry eye syndrome market size reached US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. More Info:- https://www.imarcgroup.com/dry-eye-syndrome-market

1. Global Dry Eye Syndrome
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Dry Eye Syndrome
Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2024-2032," the global dry eye syndrome market size reached US$
4.8 Billion in 2023.
Dry Eye Syndrome is a common eye condition characterized by inadequate
lubrication and moisture on the surface of the eye. It occurs when the tear
glands fail to produce enough tears or when the tears evaporate too quickly,
resulting in dryness, irritation, and discomfort. It includes symptoms such as a
gritty or sandy sensation in the eyes, redness, stinging or burning sensations,
excessive tearing, blurred vision, and sensitivity to light.
There are several underlying causes of dry eye syndrome, including aging,
hormonal changes, certain medications, medical conditions such as
autoimmune disorders, environmental factors, and lifestyle choices. Some
commonly used treatments include the use of artificial tears or lubricating eye
drops to provide temporary relief.
Request for a PDF sample of this report: https://www.imarcgroup.com/dry-
eye-syndrome-market/requestsample

4. Report Description
Global Dry Eye Syndrome Market Trends:
Lifestyle changes and increased screen time is driving the global market. Moreover, with the widespread use of
digital devices such as smartphones, tablets, and computers, individuals are exposed to prolonged periods of
screen viewing, leading to decreased blink rates and increased evaporation of tears. This prolonged visual
tasking and reduced blinking contribute to the development of dry eye symptoms, thereby fueling the demand for
DES treatments. Besides, with the global population aging, the prevalence of DES is expected to increase,
leading to a greater demand for effective treatments and management options.
Furthermore, various environmental factors, such as pollution and dry climates, are augmenting the DES market
as exposure to environmental pollutants, allergens, and irritants can trigger or exacerbate dry eye symptoms,
thus catalyzing the market. Additionally, living in regions with dry climates or spending time in air-conditioned or
heated environments can lead to increased evaporation of tears and worsened DES symptoms. Along with this,
continual advancements in diagnostic technologies and techniques have improved the accuracy and efficiency of
DES diagnosis, allowing for earlier detection and intervention. This is creating a positive market outlook.
Looking forward, the market value is projected to reach US$ 7.5 Billion by 2032, expanding at a CAGR of
5% during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/dry-eye-syndrome-market

5. Report
Segmentation
Breakup by Disease Type:
• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome
Breakup by Drug Type:
• Anti-inflammatory Drugs
• Lubricant Eye Drops
• Autologous Serum Eye Drops
Breakup by Product:
• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others

6. Report
Segmentation
Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Breakup by Region:
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

7. Competitive
Landscape with
Key Players
• Akorn Operating Company LLC
• Alimera Science
• Allergan plc.
• Auven Therapeutics
• Bausch + Lomb Incorporated
• GlaxoSmithKline plc
• Nicox S.A.
• Novartis AG
• Otsuka Holdings Co., Ltd.
• Santen Pharmaceutical Co., Ltd.

8. Key Questions
Answered in
the Report
What was the size of the global dry eye syndrome market in
2023?
What is the expected growth rate of the global dry eye
syndrome market during 2024-2032?
What are the key factors driving the global dry eye syndrome
market?
What has been the impact of COVID-19 on the global dry eye
syndrome market?
What is the breakup of the global dry eye syndrome market
based on the disease type?
What is the breakup of the global dry eye syndrome market
based on the drug type?

9. Key Questions
Answered in
the Report
What is the breakup of the global dry eye syndrome market
based on the product?
What is the breakup of the global dry eye syndrome market
based on the distribution channel?
What are the key regions in the global dry eye syndrome
market?
Who are the key companies/players in the global dry eye
syndrome market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Disease Type
5.5 Market Breakup by Drug Type
5.6 Market Breakup by Product
5.7 Market Breakup by Distribution Channels
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast

11. Table of
Contents
7 Market Breakup by Drug Type
7.1 Anti-inflammatory Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Lubricant Eye Drops
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Product
8.1 Liquid Drops
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gel
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liquid W ipes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Ointment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
For more information, visit :
https://www.imarcgroup.com/dry -eye-syndrome-market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com